A Lancet study projects a surge in liver cancer cases, reaching 1.52 million by 2050, primarily driven by obesity. Deaths are ...

ATG-022 (Claudin 18.2 antibody-drug conjugate) Title: Phase I/II study of Claudin 18.2 ADC ATG-022 in patients with advanced gastric/ gastroesophageal junction cancer (CLINCH) Abstract Number: 2907 ...

Cholangiocarcinoma, also known as bile duct cancer, is a rare disease. It's a devastating condition incurable at the point ...

The albumin-bilirubin (ALBI) score can independently predict prognosis in post-surgical patients with distal cholangiocarcinoma (dCCA), a form of cholangiocarcinoma (CCA), according to results ...

A new study has uncovered a distinct pattern of immune-related genes in hepatobiliary cancers, setting them apart from other gastrointestinal tumors.